Welcome to genXone!
We’re providing sequencing services
based on nanopore technology and
molecular diagnostics tests.
Our laboratories
Discover the quality of our services in the following areas:
next-generation sequencing (NGS) using long-read technology,
molecular diagnostics and evaluation of the effectiveness of medical products.
R&D Laboratory
We offer next-generation sequencing services using nanopore technology developed by Oxford Nanopore Technologies (ONT) and bioinformatics.
Molecular Diagnostics Laboratory
In our offer you’ll find diagnostic tests based on Real Time PCR technology and services in the fieldof evaluation of medical product performance evaluation.
Our team
Our team is built with molecular biologists, laboratory diagnosticians, bioinformaticians, administration and communication specialists. Our shared thread is passion and flexibility! This is how we create unique solutions tailored to the needs of our customers.
Stock exchange listing
Since 2021, genXone S.A. shares have been listed on the NewConnect Alternative Trading System.
Our stock ticker is GX1.
ISO 9001 certification
Quality is one of genXone’s most important values.
We have a quality management system compliant with ISO 9001:2015.
Latest blog posts:
Nanopore Day 2026
27 April 2026, genXone took part in Nanopore Day 2026 in Szczecin as a service provider. The event, …
This week events
The week just ended was full of events: 1.We attended the 9th National Microbiology Symposium “…
Let’s celebrate World Microbiome Day!
We’re celebrating World Microbiome Day with NANOBIOME! This is your chance to purchase the tes…
Do you have an idea for a research project?
Would you like to add molecular testing to your offer?
Or perhaps you want to evaluate the effectiveness of a medical product?